Education
About Us
Working with TipRanks
Follow Us
ProShares UltraShort Nasdaq Biotechnology (BIS)
NASDAQ:BIS
BIS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$14.05 - $21.10
Previous Close$17.74
Volume1.60K
Average Volume (3M)9.13K
Market Cap
$3.58M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.94
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Mar 26, 2025Dividend Yield3.15%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume12,304
30 Day Avg. Volume9,128
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
BIS FAQ
What was ProShares UltraShort Nasdaq Biotechnology’s price range in the past 12 months?
ProShares UltraShort Nasdaq Biotechnology lowest stock price was $14.05 and its highest was $21.10 in the past 12 months.
What is ProShares UltraShort Nasdaq Biotechnology’s market cap?
ProShares UltraShort Nasdaq Biotechnology’s market cap is $3.58M.
When is ProShares UltraShort Nasdaq Biotechnology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProShares UltraShort Nasdaq Biotechnology’s earnings last quarter?
Currently, no data Available
Is ProShares UltraShort Nasdaq Biotechnology overvalued?
According to Wall Street analysts ProShares UltraShort Nasdaq Biotechnology’s price is currently Overvalued.
Does ProShares UltraShort Nasdaq Biotechnology pay dividends?
ProShares UltraShort Nasdaq Biotechnology pays a Quarterly dividend of $0.132 which represents an annual dividend yield of 3.15%. See more information on ProShares UltraShort Nasdaq Biotechnology dividends here
What is ProShares UltraShort Nasdaq Biotechnology’s EPS estimate?
ProShares UltraShort Nasdaq Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProShares UltraShort Nasdaq Biotechnology have?
Currently, no data Available
What happened to ProShares UltraShort Nasdaq Biotechnology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProShares UltraShort Nasdaq Biotechnology?
Currently, no hedge funds are holding shares in BIS
---